[Changes in plasma lipid levels after the administration of beta-adrenoblockaders: possible advantages of natural sympathomimetic activity].
D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006949:Hyperlipidemias / Q000139:chemically induced / Q000517:prevention & control; D006973:Hypertension / Q000097:blood / Q000188:drug therapy*; D000960:Hypolipidemic Agents; D008055:Lipids / Q000097:blood*
D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D000960:Hypolipidemic Agents; D008055:Lipids
Izmenenie urovnia lipidov v plazme krovi pod deĭstviem beta-adrenoblokiruiushshikh sredstv: vozmozhnye preimushchestva sobstvennoĭ simpatomimeticheskoĭ aktivnosti.